Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Check whether the purity testing method is clearly listed
The Delhi High Court has opened the door for Sun Pharma to manufacture and export semaglutidebased weightloss drugs to countries where Novo Nordisk does not hold a valid patent, but has kept a firm pause on sales in India until the secondary patent runs out in March 2026
Prdida de Peso La retatrutida es un medicamento que ha cobrado atencin por su impacto en la reduccin de peso en personas con obesidad
Additional TRIUMPH and Other Phase 3 Trials Lilly has initiated or announced additional Phase 3 trials for retatrutide: Chronic low back pain -- Phase 3 initiated in Q3 2025 Overweight/obesity (additional) -- new Phase 3 trial initiated in Q3 2025 MASLD master protocol (NCT07165028) -- a Phase 3 multi-agent master protocol in MASLD that includes retatrutide (not a dedicated retatrutide-only liver trial), building on the Phase 2 liver fat sub-study TRANSCEND Program -- Type 2 Diabetes TRANSCEND Phase 3 program evaluating retatrutide specifically for type 2 diabetes
US$ 26.49
US$ 24.90
US$ 21.80
US$ 20.93
US$ 20.49
US$ 22.20
US$ 25.87
